Alere Company
Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Headquarters:
Waltham, Massachusetts, United States
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2017-08-14
Total Funding:
$512 000 000
Founded Date:
01.01.1981
Technology:
Genetic Test & Molecular Diagnostics
Estimated Revenue:
$1B to $10B
Industry:
Diagnostics
Funding Status:
M&A